Screener
Disc Medicine IRON Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest income | 6,893 | 6,880 |
| Interest expense | (844) | (897) |
| Other income (expense) | 22 | (3) |
| Total other income (expense), net | 6,071 | 5,980 |
| Loss before income taxes | (63,453) | (33,966) |
| Income tax expense | (51) | (119) |
| Net loss | $(63,504) | $(34,085) |
| Net loss per share, basic and diluted | $(1.65) | $(1.02) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Disc Medicine's other income (expense)?
- Disc Medicine (IRON) reported other income (expense) of $6.07M in Q1 2026.
- How has Disc Medicine's other income (expense) changed year-over-year?
- Disc Medicine's other income (expense) increased by 1.5% year-over-year, from $5.98M to $6.07M.
- What is the long-term trend for Disc Medicine's other income (expense)?
- Over 4 years (2021 to 2025), Disc Medicine's other income (expense) has grown at a 48.1% compound annual growth rate (CAGR), from -$5.04M to $24.2M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Disc Medicine's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude